Examination of the differences in structure-function of human and rat 3α-hydroxysteroid dehydrogenase

Chemico-Biological Interactions

Volumn 143-144, Issue , 2003, Pages 383-392

  Jin, Yi ^a   Cooper, William C ^a   Penning, Trevor M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aldo keto reductase; Bile acids; Hydroxysteroid dehydrogenase; Testosterone; Ursodeoxycholate

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TESTOSTERONE; URSODEOXYCHOLIC ACID;

CONFERENCE PAPER; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME BINDING; ENZYME RELEASE; ENZYME SPECIFICITY; ENZYME STRUCTURE; FLUORESCENCE; HUMAN; NONHUMAN; RAT; STEADY STATE; STEREOSPECIFICITY; STEROID BINDING; TITRIMETRY;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; HUMANS; MODELS, MOLECULAR; NADP; PROTEIN CONFORMATION; RATS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

KOBUS;

EID: 0037330141     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00207-7     Document Type: Conference Paper

References (28)

1. Jez M., Flynn T.G., Penning T.M. A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54:1997;639-647.
2. Jez J.M., Bennett M.J., Schlegel B.P., Lewis M., Penning T.M. Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 326:1997;625-636.
3. Jez J.M., Penning T.M. The aldo-keto reductase (AKR) superfamily: an update. Chem.-Biol. Int. 130-132:2001;499-527.
4. Pawlowski J.E., Huizinga M., Penning T.M. Cloning and sequencing of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. J. Biol. Chem. 266:1991;8820-8825.
5. Pawlowski J.E., Penning T.M. Overexpression and mutagenesis of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. J. Biol. Chem. 269:1994;13502-13510.
6. Askonas L.J., Ricigliano J.W., Penning T.M. The kinetic mechanism catalysed by homogeneous rat liver 3α-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. Biochem. J. 278:(Pt. 3):1991;835-841.
7. Schlegel B.P., Jez J.M., Penning T.M. Mutagenesis of 3α-hydroxysteroid dehydrogenase reveals a 'push-pull' mechanism for proton transfer in aldo-keto reductases. Biochemistry. 37:1998;3538-3548.
8. Hoog S.S., Pawlowski J.E., Alzari P.M., Penning T.M., Lewis M. Three-dimensional structure of rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc. Natl. Acad. Sci. USA. 91:1994;2517-2521.
9. +. Biochemistry. 35:1996;10702-10711.
10. + bound to 3α-hydroxysteroid/dihydrodiol dehydrogenase. Structure. 5:1997;799-812.
11. Hara A., Taniguchi H., Nakayama T., Sawada H. Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J. Biochem. (Tokyo). 108:1990;250-254.
12. Deyashiki Y., Taniguchi H., Amano T., Nakayama T., Hara A., Sawada H. Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3α-hydroxysteroid dehydrogenase activity. Biochem. J. 282:1992;741-746.
13. Deyashiki Y., Ogasawara A., Nakayama T., Nakanishi M., Miyabe Y., Sato K., Hara A. Molecular cloning of two human liver 3α-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. Biochem. J. 299:(Pt. 2):1994;545-552.
14. Hara A., Matsuura K., Tamada Y., Sato K., Miyabe Y., Deyashiki Y., Ishida N. Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochem. J. 313:1996;373-376.
15. Stolz A., Hammond L., Lou H., Takikawa H., Ronk M., Shively J.E. cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. J. Biol. Chem. 268:1993;10448-10457.
16. Matsuura K., Deyashiki Y., Sato K., Ishida N., Miwa G., Hara A. Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. Biochem. J. 323:1997;61-64.
17. Burczynski M.E., Harvey R.G., Penning T.M. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. Biochemistry. 37:1998;6781-6790.
18. Penning T.M., Burczynski M.E., Jez J.M., Hung C.-F., Lin H.-K., Ma H., Moore M., Palackal N., Ratnam K. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351:2000;67-77.
19. Lin H.-K., Jez J.M., Schlegel B.P., Peehl D.M., Pachter J.A., Penning T.M. Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3α/17β-HSD activity and cellular distribution. Mol. Endocrinol. 11:1997;1971-1984.
20. Dufort I., Rheault P., Huang X.-F., Soucy P., Luu-The V. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology. 140:1999;568-574.
21. Dufort I., Soucy P., Labrie F., Luu-The V. Molecular cloning of human type 3 3α-hydroxysteroid dehydrogenase that differs from 20α-hydroxysteroid dehydrogenase by seven amino acids. Biochem. Biophys. Res. Commun. 228:1996;474-479.
22. Dufort I., Labrie F., Luu-The V. Human types 1 and 3 3α-hydroxysteroid dehydrogenases: differential lability and tissue distribution. J. Clin. Endocrinol. Metab. 86:2001;841-846.
23. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors directly alter the activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. USA. 96:1999;13512-13517.
24. + and ursodeoxycholate. Biochemistry. 40:2001;10161-101688.
25. + at 1.25 Å resolution. J. Biol. Chem. 276:2001;42091-42098.
26. Kubiseski T.J., Hyndman D.J., Morjana N.A., Flynn T.G. Studies on pig muscle aldose reductase. Kinetic mechanism and evidence for a slow conformational change upon coenzyme binding. J. Biol. Chem. 267:1992;6510-6517.
27. Grimshaw C.E., Bohren K.M., Lai C.J., Gabbay K.H. Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. Biochemistry. 34:1995;14356-14365.
28. Ratnam K., Ma H., Penning T.M. Identification of the rate-limiting step in the chemical mechanism catalyzed by 3α-hydroxysteroid dehydrogenase. FASEB J. 13:1999;1113.